Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Twice Daily Pylera + Omeprazole for H. pylori
NCT00712413Phase 3Withdrawn
- Sponsor
- Forest Laboratories
- Start
- Aug 2008
- Primary completion
- Dec 2008
- Modality
- Small Molecules, Drug Delivery Systems
- Countries
- 2
01
Overview
A Phase 3 trial of bismuth subcitrate potassium + metronidazole + tetracycline hydrochloride in Helicobacter pylori infection, sponsored by Forest Laboratories. Planned start Aug 2008; status: withdrawn.
02
Drugs
bismuth subcitrate potassium + metronidazole + tetracycline hydrochloride
03
Conditions
Helicobacter pylori infection
Beyond the preview
Go deeper on NCT00712413.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00712413.